PBM DIR Fees Costing Medicare and Beneficiaries: Investigative White Paper on Background, Cost Impact, and Legal Issues

January 2017
New White Paper Reveals How Pharmacy Benefits Managers Use DIR Fees for Corporate Profit . . .
Read Full Study Here >>

2016 Practice Impact Report

,

October 2016
The 2016 Community Oncology Practice Impact Report tracks the changing landscape of cancer care in the United States.
Read Full Study Here >>

New White Paper: PBM’s Attack on Physician Dispensing and Impact on Patient Care

,

August 2016
Physician dispensing has been a critical part of the American healthcare system for decades, and dispensing physician practices have...
Read Full Study Here >>

Issue Brief: In-House and Specialty Pharmacies

August 2016
Within a community oncology practice, the in-house pharmacy provides oral and infused drugs, prescribed by the practice physicians...
Read Full Study Here >>

Bad Medicine: Oncologists Review the Evidence

May 2016
A recently released report from Memorial Sloan-Kettering Cancer Center’s (MSK) EvidenceDriven Drug Pricing Project (EDPP) ...
Read Full Study Here >>